Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
November 10, 2016
MicroRNA Expression Profiling Using Agilent One-Color Microarray
Carmela Dell'Aversana, Cristina Giorgio, Lucia Altucci
Frontiers in Endocrinology
|
October 31, 2017
Breast Cancer Vaccines: New Insights
Rosaria Benedetti, Carmela Dell'Aversana, Cristina Giorgio, et al.
Cell Death Discovery
|
December 3, 2024
TNFα-CXCR1/2 partners in crime in insulin resistance conditions
Vanessa Castelli, Housem Kacem, Laura Brandolini, et al.
Cells
|
September 28, 2021
CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
Vanessa Castelli, Laura Brandolini, Michele d'Angelo, et al.
Scientific Reports
|
October 28, 2020
NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes
Laura Brandolini, Andrea Antonosante, Cristina Giorgio, et al.
Biomedicines
|
April 30, 2021
Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives
Cristina Giorgio, Mara Zippoli, Pasquale Cocchiaro, et al.
Diabetes & Metabolism Journal
|
May 13, 2026
Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005)
Serena Boccella, Andrea Maria Morace, Cristina Giorgio, et al.
Scientific Reports
|
August 15, 2019
DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain
Laura Brandolini, Vanessa Castelli, Andrea Aramini, et al.
Diabetes & Metabolism Journal
|
November 17, 2025
Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005)
Serena Boccella, Andrea Maria Morace, Cristina Giorgio, et al.
Diabetes & Metabolism Journal
|
March 12, 2025
Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat
Serena Boccella, Andrea Maria Morace, Cristina Giorgio, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
November 10, 2016
MicroRNA Expression Profiling Using Agilent One-Color Microarray
Carmela Dell'Aversana, Cristina Giorgio, Lucia Altucci
Frontiers in Endocrinology
|
October 31, 2017
Breast Cancer Vaccines: New Insights
Rosaria Benedetti, Carmela Dell'Aversana, Cristina Giorgio, et al.
Cell Death Discovery
|
December 3, 2024
TNFα-CXCR1/2 partners in crime in insulin resistance conditions
Vanessa Castelli, Housem Kacem, Laura Brandolini, et al.
Cells
|
September 28, 2021
CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
Vanessa Castelli, Laura Brandolini, Michele d'Angelo, et al.
Scientific Reports
|
October 28, 2020
NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes
Laura Brandolini, Andrea Antonosante, Cristina Giorgio, et al.
Biomedicines
|
April 30, 2021
Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives
Cristina Giorgio, Mara Zippoli, Pasquale Cocchiaro, et al.
Diabetes & Metabolism Journal
|
May 13, 2026
Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005)
Serena Boccella, Andrea Maria Morace, Cristina Giorgio, et al.
Scientific Reports
|
August 15, 2019
DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain
Laura Brandolini, Vanessa Castelli, Andrea Aramini, et al.
Diabetes & Metabolism Journal
|
November 17, 2025
Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat (Diabetes Metab J 2025;49:990-1005)
Serena Boccella, Andrea Maria Morace, Cristina Giorgio, et al.
Diabetes & Metabolism Journal
|
March 12, 2025
Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat
Serena Boccella, Andrea Maria Morace, Cristina Giorgio, et al.
Page
of 2